Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

 84.60p
   
  • Change Today:
      0.000p
  • 52 Week High: 84.60
  • 52 Week Low: 61.00
  • Currency: UK Pounds
  • Shares Issued: 529.40m
  • Volume: 0
  • Market Cap: £447.87m
  • RiskGrade: 126

Alliance Pharma Overview

Alliance Pharma is in the pharma and biotech sector and is currently trading at 84.60p per share. In the last year Alliance Pharma's share price has ranged from 61.00p to 84.60p and brokers are currently rating this stock as 'buy'.

1 Day Chart (17-01-2020)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 1.7% 1.9%
Div Cover 3.1 3.1
Op Mrgn 20.0% 22.8%
ROCE 60.6%  
Latest F'cast
P/E 18.6 17.0
PEG n/a 1.7
Pr/Revenue 3.8 3.1
Pr/Book 1.8  
Latest F'cast
Revenue 16.3% 21.5%
PBT -19.4% 43.7%
EPS -14.8% 9.9%
DPS 10.0% 9.1%

Alliance Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 43.54 10.16 3.36p 10.9 n/a -12% 1.00p 2.7%
31-Dec-15 48.34 15.18 3.52p 12.2 2.4 +5% 1.10p 2.6%
31-Dec-16 97.49 22.22 3.85p 12.3 1.4 +9% 1.21p 2.6%
31-Dec-17 101.64 28.29 5.33p 12.6 0.3 +38% 1.33p 2.0%
31-Dec-18 118.21 22.80 4.54p 14.8 n/a -15% 1.46p 2.2%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Alliance Pharma Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 143.66 32.78 4.99p 17.0 1.7 +10% 1.60p 1.9%
31-Dec-20 152.23 35.90 5.46p 15.5 1.6 +9% 1.76p 2.1%
31-Dec-21 160.61 38.99 5.95p 14.2 1.6 +9% 1.90p 2.2%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

Alliance Pharma Company Announcements

Block Listing Six Monthly Return 06-Jan-2020 13:58 RNS
Total Voting Rights 03-Jan-2020 07:00 RNS
NOTIFICATION OF MAJOR HOLDINGS 02-Jan-2020 16:38 RNS

Alliance Pharma ShareCast News

Alliance Pharma handing back 'Xonvea' rights to ... 27-Nov-2019 ShareCast
Alliance Pharma revenues increase as product por... 17-Jul-2019 ShareCast
CMA accuses drug firms of colluding to raise NHS... 23-May-2019 ShareCast

Alliance Pharma Top Newspaper Links

Drug sales lead the way for Boots as revenues ri... 31-Oct-2008 The Scotsman
Look ahead 13-Sep-2006 Times
Look ahead 12-May-2006 Times

Latest Alliance Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 84.60p
Change Today 0.000p
% Change 0.00 %
52 Week High 84.60
52 Week Low 61.00
Volume 0
Shares Issued 529.40m
Market Cap £447.87m
RiskGrade 126

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
7.93% below the market average7.93% below the market average7.93% below the market average7.93% below the market average7.93% below the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
78.02% above the market average78.02% above the market average78.02% above the market average78.02% above the market average78.02% above the market average
68.97% above the sector average68.97% above the sector average68.97% above the sector average68.97% above the sector average68.97% above the sector average
Income
46.37% below the market average46.37% below the market average46.37% below the market average46.37% below the market average46.37% below the market average
40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average
Growth
2.32% below the market average2.32% below the market average2.32% below the market average2.32% below the market average2.32% below the market average
Sector averageSector averageSector averageSector averageSector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Interim Final
Ex-Div 19-Dec-19 13-Jun-19
Paid 10-Jan-20 11-Jul-19
Amount 0.54p 0.98p

Trades for --2020

Time Volume / Share Price
0 @ 0.000p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page